Trastuzumab beyond progression for HER2 positive metastatic breast cancer: progression-free survival on first-line therapy predicts overall survival impact (Q38225376)
Jump to navigation
Jump to search
scientific article published on July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trastuzumab beyond progression for HER2 positive metastatic breast cancer: progression-free survival on first-line therapy predicts overall survival impact |
scientific article published on July 2014 |
Statements
1 reference
Trastuzumab beyond progression for HER2 positive metastatic breast cancer: progression-free survival on first-line therapy predicts overall survival impact (English)
1 reference
Daniel Rayson
1 reference
Sarah Lutes
1 reference
Gordon Walsh
1 reference
Marlene Sellon
1 reference
Bruce Colwell
1 reference
Mark Dorreen
1 reference
Arik Drucker
1 reference
Alwin Jeyakumar
1 reference
Tallal Younis
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference